Back to Search
NICOLE FRAM, MD
MD
Ophthalmology Physician
NPI: 1114140795IndividualAccepts Medicare
Education
JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Class of 2003
Clinical Trials (2)
2
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Dexamethasone Intracanalicular Insert versus Standard Topical Steroids for the Prophylaxis of Inflammation after Cataract Surgery.
PMID 39089352·Am J Ophthalmol·2024
4-observational
Evaluating a Sustained-Release Dexamethasone Insert as Adjunctive Therapy for Inflammation and Pain Post-Corneal Transplantation.
PMID 39051020·Clin Ophthalmol·2024
5-case
RETINAL DEPOSITS OF TRIAMCINOLONE-MOXIFLOXACIN AFTER DROPLESS CATARACT SURGERY.
PMID 37643045·Retin Cases Brief Rep·2023
6-review
A Randomized, Prospective, Observer-Masked Study Comparing Dropless Treatment Regimen Using Intracanalicular Dexamethasone Insert, Intracameral Ketorolac, and Intracameral Moxifloxacin versus Conventional Topical Therapy to Control Postoperative Pain and Inflammation in Cataract Surgery.
PMID 37600148·Clin Ophthalmol·2023
5-case
Retrospective Study of a Sustained-Release Intracanalicular Dexamethasone Insert for Treatment of Ocular Inflammation After Cataract and Corneal Surgery.
PMID 36532822·Clin Ophthalmol·2022
8-other
In Clinic Optometrist Insertion of Dextenza (Dexamethasone Ophthalmic Insert 0.4mg) Prior to Cataract Surgery: The PREPARE Study.
PMID 35992569·Clin Ophthalmol·2022
8-other
Comparative Outcomes of Standard Perioperative Eye Drops, Intravitreal Triamcinolone Acetonide-Moxifloxacin, and Intracameral Dexamethasone-Moxifloxacin-Ketorolac in Cataract Surgery.
PMID 35903174·J Ophthalmol·2022
8-other
Prevalence and Characteristics of Dry Eye Disease After Cataract Surgery: A Systematic Review and Meta-Analysis.
PMID 35534685·Ophthalmol Ther·2022
6-review
The Effectiveness and Safety of Dextenza 0.4 mg for the Treatment of Postoperative Inflammation and Pain in Patients After Photorefractive Keratectomy: The RESTORE Trial.
PMID 34506241·J Refract Surg·2021
2-rct
TOXIC POSTERIOR SEGMENT SYNDROME AFTER DROPLESS CATARACT SURGERY WITH COMPOUNDED TRIAMCINOLONE-MOXIFLOXACIN.
PMID 30689622·Retina·2020
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2080 CENTURY PARK EAST, SUITE 911
LOS ANGELES, CA 90067 - Phone
- (310) 229-1220
Quick Facts
- NPI
- 1114140795
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 23
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile